Cellular immunity against cytomegalovirus (CMV) is essential for recovery from infection and control of viral latency. In immunocompromised hosts, this balance between CMV and cellular immunity is lost. Accordingly, restoration of the CD8 compartment specific for CMV is beneficial for immunocompromised patients. It is clear that CMV-specific CD4 cells provide helper functions facilitating long-term persistence of CD8 cells. Considering the dearth of data on CMV-specific T-helper cells, we investigated the CD4 responses to the immunodominant protein pp65 to define antigenic peptides. Such peptides were pooled and used to generate long-term T-cell lines. The lines were responsive to CMV and pp65. T cells were selected with individual peptides to produce monospecific lines for accurate definition of fine epitope specificity and to confirm human leukocyte antigen HLA-DR restriction. Furthermore, these lines lost alloreactivity, suggesting that they can be generated from the allodonor for adoptive immunoreconstitution of stem cell graft recipients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.humimm.2004.02.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrating clinical data and genetic susceptibility to elucidate the relationship between systemic lupus erythematosus and human cytomegalovirus infection.
Virol J
November 2024
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Key Laboratory of Rheumatology & Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, Ministry of Education, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China.
Background: Viral infections are known to induce the occurrence and pathogenesis of systemic lupus erythematosus (SLE). Previous studies have indicated a possible relationship between SLE and human cytomegalovirus (HCMV) infection and have attributed HCMV to be associated with various autoantibodies; however, these studies were constrained by variations in sample size and potential selection bias. Therefore, in the present study, we aimed to elucidate the relationship between HCMV and autoantibodies in patients with SLE by integrating clinical data and genetic susceptibility.
View Article and Find Full Text PDFVirus-specific Th17 Cells Are Induced by Human Cytomegalovirus after Renal Transplantation.
J Immunol
December 2024
Center for Vaccines and Immunity, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus OH.
Article Synopsis
- - The study investigates the connection between CMV infection and Th17 cells in kidney transplant recipients, finding that both factors independently raise the risk of late allograft loss.
- - Researchers observed that CMV-specific Th17 cells were present in blood samples and expanded during CMV reactivation, showing distinct characteristics compared to general Th17 cells.
- - The findings suggest that CMV-induced Th17 cells might play a role in causing inflammation that can lead to damage in transplanted kidneys, highlighting a possible pathway for allograft injury.
Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.
PLoS One
October 2024
Amsterdam UMC location University of Amsterdam, Laboratory for Viral Immune Pathogenesis, Amsterdam, The Netherlands.
Article Synopsis
- Antiretroviral treatment can't get rid of all the HIV in the body, and stopping treatment often doesn't help the immune system fight HIV.
- Researchers looked at T cells, a type of immune cell, in people who don't get worse from HIV (long-term non-progressors) and found that their T cells worked better due to certain signals and activities.
- The study suggests that problems with energy production in immune cells could lead to them not working properly against HIV, and improving this could help find better treatments to boost people's immune responses.
Letermovir at a Prophylactic Dose for Cytomegalovirus Infection in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study in Japan.
Biol Pharm Bull
September 2024
Department of Pharmacy, Okayama University Hospital.
Article Synopsis
- Cytomegalovirus (CMV) infection is a significant risk after hematopoietic stem cell transplantation (HSCT) in children, and this study investigates the effects of letermovir, a prophylactic treatment, on CMV infections following HSCT.
- A retrospective analysis of 79 pediatric patients showed that while the overall incidence of CMV infection was not significantly different between those who received letermovir and those who did not, letermovir was associated with a lower incidence of CMV infection in the first 100 days post-transplant.
- Despite minimal side effects, such as nausea in one case, the findings suggest that letermovir could be an effective preventive measure against CMV in children undergoing HSCT.
T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection.
JCI Insight
September 2024
Department of Pediatrics, Division of Infectious Diseases, and.
BACKGROUNDCongenital cytomegalovirus (cCMV) infection can cause developmental impairment and sensorineural hearing loss (SNHL). To determine the relationship between immune responses to cCMV infection and neurologic sequelae, T cell responses were compared for their connection to clinical symptoms at birth and neurodevelopmental outcomes.METHODSThirty cCMV-infected and 15 uninfected infants were enrolled in a single-center prospective observational case-control study.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!